Charles Schwab Investment Management Inc. lifted its holdings in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE – Free Report) by 0.7% during the 4th quarter, HoldingsChannel reports.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results